23 April 2026
In north London, the future possibilities of optometry are being brought to life at the newly-opened Topcon Healthcare Innovation Centre (THINC EMEA).
THINC EMEA is an incubator for technology start-ups focused on oculomics, the centre's head of digital health solutions and clinical development, Krysten Williams, told OT at this year’s 100% Optical.
THINC, which has now opened its doors to collaborators, is aiming to give start-ups the power to bring technologies focused on the emerging field of oculomics to the commercial healthcare market.
The hub is part of a larger initiative, which started three years ago in San Diego. London is the home of the second THINC location, focusing on the acceleration of artificial intelligence (AI), specifically in the field of oculomics.
Oculomics, the method of diagnosing systemic health conditions and diseases via imaging, is gaining traction after the term was initially coined at Moorfields Eye Hospital/UCL in 2020.
The aim of THINC is to incubate potential technology that is using oculomics in order to “bring the eye to the centre of health,” Williams told OT.
The unique properties of the eye mean that clinicians can look at vascular structure and brain tissue at the same time, allowing them to differentiate “hundreds of systemic diseases in the body,” she explained.
This is what THINC’s London outpost aims to do: accelerate the development of these technologies, investing and providing the infrastructure and clinical and commercial support that can bring products to market.
The model has borne fruit in San Diego, where 16 start-ups have received THINC funding over the past 18 months.
A decision was taken to open the London THINC hub to focus on the needs of Europe, Williams told OT.
The centre, in Camden, was officially opened with an evening celebration on Thursday 16 April.
“We are looking for start-ups that want investment, and then we put them through our venture capital group process to determine whether or not their mission and their vision [aligns with ours], which is to deliver healthcare from the eye,” Williams shared with OT.
Existing projects include a start-up making an algorithm for age-related macular degeneration and geographical atrophy, a referral platform for diabetic retinopathies, and an AI algorithm that assess biological age by cardiovascular risk perceptions and kidney conversion, she explained.
Williams told OT that THINC’s most recent acquisition, launched at 100% Optical, is from Toku Eyes, and is their first AI algorithm focusing on oculomics.
Williams explained that the technology “is based on a fundus image and is a simple eye scan, non-invasive. It gives a cardiovascular risk score, and then the patient receives a report of their own and a QR code, and they go online, and they can get information about what they should do, how they can improve their lifestyle, and what they should do in regards to outcomes.”
In explaining how the THINC model works more broadly, Williams said: “These startup companies live within the innovation centre, and we accelerate their development in several ways.
“Topcon supports commercialisation. We have experience with establishing a quality management system and regulatory pathways. We can assist with market research. We can provide the distribution channels. We can perform clinical trials.”
She added: “We can provide all of these services that may be challenging for start-ups, so they can focus on developing their products.”
Collaborations for the future
THINC had its own stand at 100% Optical 2026, with the aim of fostering relationships with potential partners for the future.
The long-term aim is to work with optometric researchers and industry bodies and bring all stakeholders who are involved in patient care, including those outside of eye care, together to create “connected care,” Williams said.
The 100% Optical stand provided an opportunity to show delegates “what is coming in the future,” she added.
Williams told OT: “We’re looking for collaborators, because we can’t do this alone. In order to bring oculomics to the market, we need to change the way healthcare is delivered.”
THINC must work with a wide variety of organisations in order to bring products to market, navigate regulatory frameworks, lobby the Government and ultimately make tests available to people, including on the NHS, she said, adding that THINC wants to “change the way healthcare is delivered.”
Ultimately, “with a simple eye scan, we will be able to provide more insight into diseases like AMD and diabetes, as well as cardiovascular risk, kidney function and neurodegenerative diseases, like dementia and Alzheimer's,” Williams believes.
This presents an opportunity for optometry, Williams told OT – but that work needs to be done to ensure that eye care practitioners’ input is valued.
If optometrists are “the gatekeepers of the eye” and are able to bring the eye to the centre of healthcare, patient pathways and pay models need to change, she said.
Industry must partner with professional bodies and payers in order to influence this, she emphasised.
Scalable businesses and patient value
OT was interested in finding out key things that those working at THINC would like optometrists, and by extension start-up entrepreneurs, to know about the centre’s offering.
For start-ups, “We want to make sure we make oculomics successful in the long term. We are a long-term partner,” Williams said.
As part of a global organisation that has a “huge resource pool,” THINC can support start-ups in areas that they may not think about as they develop their products – for example sustainability, Williams said.
The same is true for regulatory pathways, she said: “A start-up may be developing an algorithm for a pharmaceutical company to do a clinical trial, but they haven’t thought about the regulatory pathway to bring that product to market.
“And so, that’s what we do. It’s those types of services that we offer to start-ups that make it attractive to work [with us].”
When it comes to optometrists, Williams wants to emphasise that THINC’s offering is all about accelerating the technologies that could become available to them in the coming years.
She also noted that optometrists are in a strong position to be at the forefront of these developments.
In her career, which has included roles at Zeiss Vision, Hoya and Seiko, she has seen “optometrists who are brave enough to be early adopters of technology [who] have driven the technological change,” Williams said.
She explained: “They drive change into the NHS, because they bring it to the patient, the patient pays for it themselves, and they then change the standard of care.”
She added: “Optometrists can become the gatekeepers of the eye. The great thing about optometry is that it’s all about pattern recognition. They [optometrists] understand the patterns that they see in the images, and they're uniquely skilled.”
Williams added: “As optometrists use AI, they will become better and better at what they do. They will be able to [further] differentiate. AI provides a huge opportunity for optometrists to grab with both hands.”
Williams also explained that THINC is focused on collecting the clinical data to back up the work that it is accelerating.
“We’re collecting data in order to be able to make that data available to researchers, so that we can validate the algorithms, so that they become more robust, and we have the clinical evidence to back it up,” she said.
THINC is currently recruiting optometrists who are willing to consent their patients to be part of a database of images that can be used for the development of AI models, Williams explained.
A data hub – the Institute of Digital Health – has also been created, allowing researchers to access data sets that they can use in their work.
Williams summed up the purpose of THINC succinctly to OT.
“I get up in the morning and I think, ‘how am I going to accelerate healthcare from the eye today?’ Whether that is making a partnership with another organisation that can help to drive things, or whether it is finding a research optometrist, whether it is running a clinical trial to build clinical evidence, or helping a start-up to go faster so that they can bring their product to market – that is what THINC does,” she said.
Comments (0)
You must be logged in to join the discussion. Log in